278 related articles for article (PubMed ID: 28501127)
81. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
82. Increased expression of C-C motif ligand 2 associates with poor prognosis in patients with gastric cancer after gastrectomy.
Liu H; Shen Z; Wang X; Zhang H; Qin J; Qin X; Xu J; Sun Y
Tumour Biol; 2016 Mar; 37(3):3285-93. PubMed ID: 26438062
[TBL] [Abstract][Full Text] [Related]
83. Clinical utility of perioperative staging laparoscopy for advanced gastric cancer.
Ishigami S; Uenosono Y; Arigami T; Yanagita S; Okumura H; Uchikado Y; Kita Y; Kurahara H; Kijima Y; Nakajo A; Maemura K; Natsugoe S
World J Surg Oncol; 2014 Nov; 12():350. PubMed ID: 25407392
[TBL] [Abstract][Full Text] [Related]
84. Surgical outcome of node-positive early gastric cancer with particular reference to nodal status.
Kikuchi S; Sato M; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Kakita A
Anticancer Res; 2000; 20(5C):3695-700. PubMed ID: 11268441
[TBL] [Abstract][Full Text] [Related]
85. The clinicopathologic significance of Tks5 expression of peritoneal mesothelial cells in gastric cancer patients.
Sugimoto A; Okuno T; Tsujio G; Sera T; Yamamoto Y; Maruo K; Kushiyama S; Nishimura S; Kuroda K; Togano S; Miki Y; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
PLoS One; 2021; 16(7):e0253702. PubMed ID: 34255789
[TBL] [Abstract][Full Text] [Related]
86. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients.
Choi HS; Ha SY; Kim HM; Ahn SM; Kang MS; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kang ES
Oncotarget; 2016 Feb; 7(7):7940-51. PubMed ID: 26799288
[TBL] [Abstract][Full Text] [Related]
87. Metabolomic profiling of gastric cancer tissues identified potential biomarkers for predicting peritoneal recurrence.
Kaji S; Irino T; Kusuhara M; Makuuchi R; Yamakawa Y; Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Kami K; Ohashi Y; Zhang S; Orita H; Lee-Okada HC; Fukunaga T; Terashima M
Gastric Cancer; 2020 Sep; 23(5):874-883. PubMed ID: 32219586
[TBL] [Abstract][Full Text] [Related]
88. Oncologic outcomes of laparoscopy-assisted distal gastrectomy for gastric cancer.
Fukunaga T; Hiki N; Kubota T; Nunobe S; Tokunaga M; Nohara K; Sano T; Yamaguchi T
Ann Surg Oncol; 2013 Aug; 20(8):2676-82. PubMed ID: 23709054
[TBL] [Abstract][Full Text] [Related]
89. Magnitude of serosal changes predicts peritoneal recurrence of gastric cancer.
Bando E; Kawamura T; Kinoshita K; Takahashi S; Maeda A; Osada S; Tsubosa Y; Yamaguchi S; Uesaka K; Yonemura Y
J Am Coll Surg; 2003 Aug; 197(2):212-22. PubMed ID: 12892799
[TBL] [Abstract][Full Text] [Related]
90. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
91. Gastric cancer with metastases to the distant peritoneum: a 20-year surgical experience.
Kikuchi S; Arai Y; Morise M; Kobayashi N; Tsukamoto H; Shimao H; Sakakibara Y; Hiki Y; Kakita A
Hepatogastroenterology; 1998; 45(22):1183-8. PubMed ID: 9756030
[TBL] [Abstract][Full Text] [Related]
92. VEGF significance in peritoneal recurrence from gastric cancer.
Aoyagi K; Kouhuji K; Yano S; Miyagi M; Imaizumi T; Takeda J; Shirouzu K
Gastric Cancer; 2005; 8(3):155-63. PubMed ID: 16086118
[TBL] [Abstract][Full Text] [Related]
93. Relationship Between 18F-FDG Uptake on PET and Recurrence Patterns After Curative Surgical Resection in Patients with Advanced Gastric Cancer.
Lee JW; Jo K; Cho A; Noh SH; Lee JD; Yun M
J Nucl Med; 2015 Oct; 56(10):1494-500. PubMed ID: 26251414
[TBL] [Abstract][Full Text] [Related]
94. Peritoneal dissemination of early gastric cancer: report of a case.
Yamamoto M; Taguchi K; Baba H; Endo K; Kohnoe S; Okamura T; Maehara Y
Surg Today; 2006; 36(9):835-8. PubMed ID: 16937291
[TBL] [Abstract][Full Text] [Related]
95. CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma.
Maruyama T; Kono K; Izawa S; Mizukami Y; Kawaguchi Y; Mimura K; Watanabe M; Fujii H
Dis Esophagus; 2010 Jul; 23(5):422-9. PubMed ID: 20002703
[TBL] [Abstract][Full Text] [Related]
96. Expression of cellular retinoic acid binding protein 1 predicts peritoneal recurrence of gastric cancer.
Sakata K; Kanda M; Shimizu D; Nakamura S; Inokawa Y; Hattori N; Hayashi M; Tanaka C; Nakayama G; Kodera Y
Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35417033
[TBL] [Abstract][Full Text] [Related]
97. Tissue
Sasahara M; Kanda M; Shimizu D; Tanaka C; Inokawa Y; Hattori N; Hayashi M; Nakayama G; Kodera Y
Anticancer Res; 2021 Feb; 41(2):609-617. PubMed ID: 33517265
[TBL] [Abstract][Full Text] [Related]
98. Intraoperative blood loss is a critical risk factor for peritoneal recurrence after curative resection of advanced gastric cancer.
Kamei T; Kitayama J; Yamashita H; Nagawa H
World J Surg; 2009 Jun; 33(6):1240-6. PubMed ID: 19308640
[TBL] [Abstract][Full Text] [Related]
99. Prospective study of peritoneal recurrence after curative surgery for gastric cancer.
Roviello F; Marrelli D; de Manzoni G; Morgagni P; Di Leo A; Saragoni L; De Stefano A;
Br J Surg; 2003 Sep; 90(9):1113-9. PubMed ID: 12945079
[TBL] [Abstract][Full Text] [Related]
100. Clinical significance of telomerase activity in peritoneal lavage fluid from patients with gastric cancer and its relationship with cellular proliferation.
Da MX; Wu XT; Guo TK; Zhao ZG; Luo T; Qian K; Zhang MM; Wang J
World J Gastroenterol; 2007 Jun; 13(22):3122-7. PubMed ID: 17589931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
